Chiral separation of Etozolin (Ethyl(3-Methyl-4-Oxo-5- Piperidinothiazolidin-2-ylidene)Acetate)
Applications | | KNAUERInstrumentation
Chiral separation of pharmaceutical compounds like Etozolin is crucial for ensuring efficacy and safety in diuretic therapy. The enantiomers of Etozolin may exhibit different pharmacological activities and side effects.
The primary goal was to achieve baseline separation of Etozolin enantiomers using chiral HPLC with a cellulose-based stationary phase. The study outlines method development and optimization for reliable enantioselective analysis.
The method achieved capacity factors of k΄1 = 0.68 and k΄2 = 1.05, yielding an enantioselectivity (α) of 1.54. Peaks were sharp and retention times reproducible, confirming effective enantiomeric discrimination under the chosen conditions.
Emerging developments may include coupling chiral HPLC with mass spectrometry for enhanced sensitivity, adoption of ultrahigh-pressure liquid chromatography (UHPLC) to shorten analysis times, and exploration of novel chiral selectors for improved selectivity and robustness.
The developed chiral HPLC method using the Eurocel 01 stationary phase provides reliable, reproducible separation of Etozolin enantiomers, supporting pharmaceutical analysis and quality assurance efforts.
Consumables, LC columns, HPLC
IndustriesManufacturerKNAUER
Summary
Significance of the Topic
Chiral separation of pharmaceutical compounds like Etozolin is crucial for ensuring efficacy and safety in diuretic therapy. The enantiomers of Etozolin may exhibit different pharmacological activities and side effects.
Aims and Overview of the Study
The primary goal was to achieve baseline separation of Etozolin enantiomers using chiral HPLC with a cellulose-based stationary phase. The study outlines method development and optimization for reliable enantioselective analysis.
Methodology
- Technique: Chiral high-performance liquid chromatography
- Stationary Phase: Eurocel 01 (cellulose-based), 5 µm, 250 × 4.6 mm ID
- Eluent: Methanol (isocratic)
- Flow Rate: 1.0 mL/min
- Injection Volume: 10 µL
- Column Temperature: 25 °C
- Detection: UV at 220 nm
Main Results and Discussion
The method achieved capacity factors of k΄1 = 0.68 and k΄2 = 1.05, yielding an enantioselectivity (α) of 1.54. Peaks were sharp and retention times reproducible, confirming effective enantiomeric discrimination under the chosen conditions.
Benefits and Practical Applications
- Quality Control: Enables routine assessment of enantiomeric purity in pharmaceutical manufacturing.
- Regulatory Compliance: Supports documentation required for chiral drug approval processes.
- Research Utility: Facilitates studies on enantiomer-specific pharmacodynamics and pharmacokinetics.
Future Trends and Applications
Emerging developments may include coupling chiral HPLC with mass spectrometry for enhanced sensitivity, adoption of ultrahigh-pressure liquid chromatography (UHPLC) to shorten analysis times, and exploration of novel chiral selectors for improved selectivity and robustness.
Conclusion
The developed chiral HPLC method using the Eurocel 01 stationary phase provides reliable, reproducible separation of Etozolin enantiomers, supporting pharmaceutical analysis and quality assurance efforts.
Used Instrumentation
- HPLC system equipped with UV detector set at 220 nm
- Eurocel 01 Chiral Column (5 µm, 250 × 4.6 mm ID)
- Pump module delivering isocratic methanol flow
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Chiral separation of Abscisic Acid (4-Oxo-2-Cyclohexen-1-yl)-3- Methyl-2,4-Pentanedienoic Acid)
|KNAUER|Applications
Chiral separation of Abscisic Acid (4-Oxo-2-Cyclohexen-1-yl)-3Methyl-2,4-Pentanedienoic Acid) Method HPLC VCR0005J Chiral HPLC Column: Eurocel 01 5 µm, 250 x 4.6 mm ID Phase: Eurocel 01, 5 µm Conditions: Eluent: Gradient: Flow rate: Temperature: Volume: Detection: UV at 230 nm Substances:…
Key words
hplc, hplcchiral, chiralisocratic, isocraticmethod
Chiral separation of Warfarin (4-Hydroxy-3-(3-Oxo-1-Phenyl-Butyl)- Cumarin)
|KNAUER|Applications
Chiral separation of Warfarin (4-Hydroxy-3-(3-Oxo-1-Phenyl-Butyl)Cumarin) Method HPLC VCR0048J Chiral HPLC Column: Eurocel 01 5 µm, 250 x 4.6 mm ID Phase: Eurocel 01, 5 µm Conditions: Eluent: Gradient: Flow rate: Temperature: Volume: Detection: UV at 270 nm Substances: Warfarin (4-Hydroxy-3-(3-Oxo-1-Phenyl-Butyl)-Cumarin)…
Key words
hplc, hplcchiral, chiralisocratic, isocraticminutes, minutesmethod
Chiral separation of Diclofop – methyl
|KNAUER|Applications
Chiral separation of Diclofop – methyl Method HPLC VCR0023J Chiral HPLC Column: Eurocel 01, 250 x 4.6 mm ID with precolumn Order No. Phase: Eurocel 01, 5 µm Conditions: Eluent: Gradient: Flow rate: Temperature: Volume: Detection: UV at 210 nm…
Key words
chiral, chiraldiclofop, diclofopprecolumn, precolumnhplc, hplcisocratic, isocraticmethyl, methylseparation, separationmethod
Chiral separation of Naproxen (6-Methoxy-α-Methyl-2- Naphthylessigsäure)
|KNAUER|Applications
Chiral separation of Naproxen (6-Methoxy-α-Methyl-2Naphthylessigsäure) Method HPLC VCR0038J Chiral HPLC Column: Eurocel 01 5 µm, 250 x 4.6 mm ID Phase: Eurocel 01, 5 µm Conditions: Eluent: Gradient: Flow rate: Temperature: Volume: Detection: UV at 230 nm Substances: Naproxen (6-Methoxy-α-Methyl-2-Naphthylessigsäure)…
Key words
hplc, hplcchiral, chiralisocratic, isocraticmau, mauminutes, minutesmethod